Inventor · disambiguated record
Linh Q. Le
Also filed as: LE LINH Q
4 granted patents·5 pending applications·14 citations·filing 2010–2022
71Inventor score
Top patents by PatentIndex Score
9 records- 0186US9938514B2Methods of intracellular conversion of single-chain proteins into their di-chain formALLERGAN INC·Filed 2016·Granted Apr 10, 2018·3 cites·5 claims
- 0285US9340813B2Methods of intracellular conversion of single-chain proteins into their di-chain formALLERGAN INC·Filed 2013·Granted May 17, 2016·4 cites·2 claims
- 0384US8546108B2Methods of intracellular conversion of single-chain proteins into their di-chain formGHANSHANI SANJIV·Filed 2011·Granted Oct 1, 2013·7 cites·15 claims
- 0473US2023302103A1Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2022·Application pending·0 cites
- 0571US10912823B2Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2018·Granted Feb 9, 2021·0 cites·20 claims
- 0665US2021162027A1Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melaninALLERGAN INC·Filed 2021·Application pending·0 cites
- 0757US2023332126A1Botulinum Neurotoxin Proteins and Methods to Engineer and Generate SameUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0850US2014127784A1Modified clostridial toxins comprising an integrated protease cleavage site-binding domainALLERGAN INC·Filed 2014·Application pending·0 cites
- 0944US2011189162A1Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding DomainALLERGAN INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →